Rapidly screening counterfeit drugs using near infrared spectroscopy: Combining qualitative analysis with quantitative analysis to increase effectiveness

Journal of Near Infrared Spectroscopy

Volumn 16, Issue 3, 2008, Pages 349-355

  Lei, Yi ^a   Luo, Zhuo Ya ^a   Hu, Chang Qin ^b  

^a Guang Dong Institute For Drug Control   (China)

^b NATIONAL INSTITUTE FOR THE CONTROL OF PHARMACEUTICAL AND BIOLOGICAL PRODUCTS   (China)

Author keywords

Generic drug; Near infrared spectroscopy; Qualitative model; Quantitative model; Screening counterfeit drugs; Vitamin tablet

Indexed keywords

EID: 49649125651     PISSN: 09670335     EISSN: None     Source Type: Journal    
DOI: 10.1255/jnirs.798     Document Type: Conference Paper

References (23)

1. http://www.who.int/medicines/services/counterfeit/impact/lmpactF_S/en/.
2. M.D. Green, P. Newton, F. Fernandez, R. Wirtz and H. Nettey, "Simple low-cost strategies to rapidly identify counterfeit drugs in developing countries", in Combating Pharmaceutical Fraud and Counterfeiting, SMI Conference Documentation, London, UK. SMI Publishing, London, UK (2003).
3. J. Bassett, R.C. Denney, G.H. Jeffery and J. Mendham, Vogel's Textbook of Quantitative Inorganic Analysis. Longman Scientific Publishers, London, UK, p. 693 (1978).
4. P. Newton, S. Proux, M. Green, F. Smithius, N. Phu, J. Rozendaal, S. Prakongpan, K. Chotivanich, M. Mayxay, F. Noslen and N. White, Lancet 357, 1948 (2001). doi: 10.1016/S0140-6736(00)05085-6
5. M.D. Green, D.L. Mount, R.A. Wirtz and N.J. White, J. Pharm. Biomed. Anal, 24, 65 (2000). doi: 10.1016/S0731-7085(00)00360-5
6. http://www.gphf.org/web_en/projekte/minilab/index.htm, 2003.
7. R. Jahnke, "The GPHF-Minilab Project", in Combating Pharmaceutical Fraud and Counterfeiting, SMI Conference Documentation, London, UK. SMI Publishing, London, UK (2003).
8. M. Blanco, J. Coello, H. Iturriaga, S. Maspoch, C. de la Pezuela and E. Russo, Anal. Chim. Acta 298, 183 (1994). doi: 10.1016/0003- 2670(94)00275-4
9. F. González and R. Pous, J. Pharm. Biomed. Anal. 10, 419 (1995) doi: 10.1016/0731-7085(95)01333-G
10. P.J. Gemperline, L.D. Webber and I.O. Lox, Anal. Chem. 61, 139 (1989).
11. R.A. Lodder and G.M. Hieftje, Appl. Spectrosc. 42, 556 (1988). doi: 10.1366/0003702884429201
12. M. Blanco, J. Coello, H. Iturriaga, S. Maspoch and C. de la Pezuela, Talanta 40, 1671 (1993). doi: 10.1016/0039-9140(93)80083-4
13. M. Blanco, J. Coello, H. Iturriaga, S. Maspoch and C. de la Pezuela, Analyst 122, 761 (1997). doi: 10.1039/a700630f
14. S.M. Han and P.G. Faulkner, J. Pharm. Biomed. Anal. 14, 1691 (1996). doi: 10.1016/0731-7085(96)01814-6
15. J.K. Drennen and R.A. Lodder, J. Pharm. Sci. 79, 622 (1990). doi: 10.1002/jps.2600790717
16. J. Luypaert, D.L. Massart and Y. Vander Heyden, Talanta 72, 865 (2007). doi: 10.1016/j.talanta.2006.12.023
17. S.H.F. Scafi and C. Pasquini, Analyst 126, 2218 (2001). doi: 10.1039/b106744n
18. F.C. Clarke, S.V. Hammond, R.D. Jee and A.C. Moffat, Appl. Spectrosc. 56, 1475 (2002). doi: 10.1366/00037020260377797
19. S.H.F. Scafi and C. Pasquini, Analyst 126, 2218 (2001). doi: 10.1039/b106744n
20. B.A. Olsen, M.W. Borer, F.M. Perry and R.A. Forbes, Pharmaceut. Technol. 26, 62 (2002).
21. The State Pharmacopoeia Commission of The People's Republic of China, Pharmacopoeia of the People's Republic of China. Chemical Industry Press, Beijing, People's Republic of China (2005).
22. R.W.O. Jähnke, G. Küsters and K. Fleischer. Drug. Inf. J. 35, 941 (2001).
23. Y.C. Feng and C.Q. Hu, J. Pharm. Biomed. Anal. 41, 373 (2006). doi: 10.1016/j.jpba.2005.11.027